OR WAIT null SECS
May 03, 2024
Per the US strategic partnership agreement, the adalimumab high-concentration interchangeable biosimilar will be distributed under the Quallent Pharmaceuticals private label.
May 02, 2024
The partnership revolves around augmenting regulatory compliance, along with drug sampling distribution and compliance.
May 01, 2024
The CRO earned a Bronze rating for criteria based on environmental, social, and ethical performance.
IATA data points to a fourth consecutive month of double-digit, year-on-year growth.
April 29, 2024
The CDMO’s boost in production will be centered around pharmaceutical products.
April 26, 2024
There is no doubt that drug shortages are a detriment to the pharma supply chain, but how commonplace were they during the COVID era?
The move features the launch of an innovation center revolving around cell and gene services.
April 18, 2024
Session addresses the challenges of implementing autologous/allogeneic cell gene therapies into scalable networks.
A panel uncovers the value in meeting carbon-neutral goals by 2030.
April 17, 2024
Masterclass session addresses looking beyond a dashboard by added capabilities with added value.